Related references
Note: Only part of the references are listed.Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Juraj Koska et al.
DIABETES CARE (2022)
The AGE Reader: A non-invasive method to assess long-term tissue damage
I. M. Atzeni et al.
METHODS (2022)
Ultra-Processed Food Consumption and Adult Mortality Risk: A Systematic Review and Dose-Response Meta-Analysis of 207,291 Participants
Wanich Suksatan et al.
NUTRIENTS (2022)
A 4-week high-AGE diet does not impair glucose metabolism and vascular function in obese individuals
Armand M. A. Linkens et al.
JCI INSIGHT (2022)
Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19
Efrat Gur et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2022)
Sodium Ions Affect Pyrraline Formation in the Maillard Reaction With Lys-Containing Dipeptides and Tripeptides
Zhili Liang et al.
FRONTIERS IN NUTRITION (2022)
Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study
Francisco M. Gutierrez-Mariscal et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2021)
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis
Patricia M. Bock et al.
DIABETOLOGIA (2021)
Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study
Marci Laudenslager et al.
DIGESTIVE AND LIVER DISEASE (2021)
Changes in ultra-processed food consumption during the first Italian lockdown following the COVID-19 pandemic and major correlates: results from two population-based cohorts
Marialaura Bonaccio et al.
PUBLIC HEALTH NUTRITION (2021)
Advanced glycation end products as predictors of renal function in youth with type 1 diabetes
Josephine M. Forbes et al.
SCIENTIFIC REPORTS (2021)
Processed foods drive intestinal barrier permeability and microvascular diseases
Matthew Snelson et al.
SCIENCE ADVANCES (2021)
Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals
Francesco Scavello et al.
BIOMARKERS IN MEDICINE (2021)
Trends in Consumption of Ultraprocessed Foods Among US Youths Aged 2-19 Years, 1999-2018
Lu Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial
Roni Lotan et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria
Rajkishor Nishad et al.
FRONTIERS IN MEDICINE (2021)
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)
Aowen Zhuang et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2021)
Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial
Mahdieh Abbasalizad Farhangi et al.
EUROPEAN JOURNAL OF NUTRITION (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Ultraprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Sante Prospective Cohort
Bernard Srour et al.
JAMA INTERNAL MEDICINE (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Changes of Physical Activity and Ultra-Processed Food Consumption in Adolescents from Different Countries during Covid-19 Pandemic: An Observational Study
Maria Belen Ruiz-Roso et al.
NUTRIENTS (2020)
Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation
Raffaella Mastrocola et al.
NUTRIENTS (2020)
Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology
Matthew Snelson et al.
NUTRIENTS (2019)
Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans
Ryan K. Perkins et al.
NUTRIENTS (2019)
Association Between Ultraprocessed Food Consumption and Risk of Mortality Among Middle-aged Adults in France
Laure Schnabel et al.
JAMA INTERNAL MEDICINE (2019)
Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study
Anais Rico-Campa et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Sante)
Bernard Srour et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients
Camilo G. Sotomayor et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
Aowen Zhuang et al.
SCIENTIFIC REPORTS (2019)
Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions
Thibault Teissier et al.
AGING CELL (2019)
Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women
Javier Lopez-Moreno et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
AGE Content of a Protein Load Is Responsible for Renal Performances: A Pilot Study
Gabrielle Normand et al.
DIABETES CARE (2018)
RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice
Kensei Taguchi et al.
SCIENTIFIC REPORTS (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome
Javier Lopez-Moreno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
A subcellular map of the human proteome
Peter J. Thul et al.
SCIENCE (2017)
Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial
Estifanos Baye et al.
SCIENTIFIC REPORTS (2017)
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial
Rabi Yacoub et al.
PLOS ONE (2017)
The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes
Ronald Klein et al.
DIABETES CARE (2017)
Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort
Stephanie J. Loomis et al.
CLINICAL CHEMISTRY (2017)
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy
Takanori Matsui et al.
DIABETES (2017)
Autophagy Inhibits the Accumulation of Advanced Glycation End Products by Promoting Lysosomal Biogenesis and Function in the Kidney Proximal Tubules
Atsushi Takahashi et al.
DIABETES (2017)
Uremic Toxicity of Advanced Glycation End Products in CKD
Andrea E. M. Stinghen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial
Barbora de Courten et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus
P. Anil Kumar et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
Pierre-Jean Saulnier et al.
DIABETES (2016)
Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database
Jean L. J. M. Scheijen et al.
FOOD CHEMISTRY (2016)
Targeting advanced glycation with pharmaceutical agents: where are we now?
Danielle J. Borg et al.
GLYCOCONJUGATE JOURNAL (2016)
Dietary Advanced Glycation End Products and Risk of Chronic Kidney Disease
Hanieh-Sadat Ejtahed et al.
JOURNAL OF RENAL NUTRITION (2016)
Quantitative assessment of organ distribution of dietary protein-bound 13C-labeled Nε-carboxymethyllysine after a chronic oral exposure in mice
Frederic J. Tessier et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials
Rachel E. Clarke et al.
NUTRIENTS (2016)
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Anna Machowska et al.
PLOS ONE (2016)
The Western Diet and Chronic Kidney Disease
Divya Hariharan et al.
CURRENT HYPERTENSION REPORTS (2015)
Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Merlin C. Thomas et al.
DIABETES CARE (2015)
Increased Accumulation of Protein-Bound Nε-(Carboxymethyl)lysine in Tissues of Healthy Rats after Chronic Oral Nε-(Carboxymethyl)lysine
Mei Li et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy
Wei Jing Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats
Adriano M. de Assis et al.
NUTRITION RESEARCH (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
Saul Genuth et al.
DIABETES (2015)
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
Casey M. Rebholz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
Masayoshi Takeuchi et al.
PLOS ONE (2015)
Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease
Kailash Prasad et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2015)
Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women
Alicja Budek Mark et al.
DIABETES CARE (2014)
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes
Greg Tesch et al.
DIABETOLOGIA (2014)
Dietary glycotoxins exacerbate progression of experimental fatty liver disease
Christopher Leung et al.
JOURNAL OF HEPATOLOGY (2014)
Dietary Intake of Advanced Glycation End Products Did Not Affect Endothelial Function and Inflammation in Healthy Adults in a Randomized Controlled Trial
Richard D. Semba et al.
JOURNAL OF NUTRITION (2014)
Maillard reaction products modulate gut microbiota composition in adolescents
Isabel Seiquer et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial
Nicole J. Kellow et al.
BMC ENDOCRINE DISORDERS (2014)
Digestibility of extruded proteins and metabolic transit of Nε-carboxymethyllysine in rats
Issam Alamir et al.
AMINO ACIDS (2013)
Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis
Marisa A. Gallicchio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Jianling Xie et al.
CELLULAR SIGNALLING (2013)
sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
Elizabeth Selvin et al.
DIABETES (2013)
DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
Yusuke Kaida et al.
DIABETES (2013)
Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus
M. Genevieve et al.
DIABETES & METABOLISM (2013)
Skin Autofluorescence Reflects Integration of Past Long-Term Glycemic Control in Patients With Type 1 Diabetes
Eri Sugisawa et al.
DIABETES CARE (2013)
The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study
Trevor J. Orchard et al.
DIABETES CARE (2013)
Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products
Paul J. Beisswenger et al.
DIABETES CARE (2013)
Advanced glycation endproducts in food and their effects on health
Malene W. Poulsen et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases
Nitin Mahajan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Glucose homeostasis can be differentially modulated by varying individual components of a western diet
Josephine M. Forbes et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Biodistribution and Elimination Study of Fluorine-18 Labeled Nε-Carboxymethyl-Lysine following Intragastric and Intravenous Administration
Hongzeng Xu et al.
PLOS ONE (2013)
Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis
Martijn A. M. den Dekker et al.
PLOS ONE (2013)
Skin Autofluorescence Is Associated with the Progression of Chronic Kidney Disease: A Prospective Observational Study
Kenichi Tanaka et al.
PLOS ONE (2013)
Metabolic transit of Nε-carboxymethyl-lysine after consumption of AGEs from bread crust
Irene Roncero-Ramos et al.
FOOD & FUNCTION (2013)
Study of the urinary and faecal excretion of N ε-carboxymethyllysine in young human volunteers
Cristina Delgado-Andrade et al.
AMINO ACIDS (2012)
Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1
Stefanie Grimm et al.
BIOCHEMICAL JOURNAL (2012)
RAGE binds C1q and enhances C1q-mediated phagocytosis
Wanchao Ma et al.
CELLULAR IMMUNOLOGY (2012)
Nε-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet
George L. J. Hull et al.
FOOD CHEMISTRY (2012)
Effect of Dietary Advanced Glycation End Products on Mouse Liver
Raza Patel et al.
PLOS ONE (2012)
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
Weijing Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Endogenous Secretory Receptor for Advanced Glycation End Products and Chronic Kidney Disease in the Elderly Population
Mansi Dalal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Temporal Increases in Urinary Carboxymethyllysine Correlate with Albuminuria Development in Diabetes
Melinda T. Coughlan et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Advanced Glycation Urinary Protein-Bound Biomarkers and Severity of Diabetic Nephropathy in Man
Melinda T. Coughlan et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Skin Autofluorescence and the Association with Renal and Cardiovascular Risk Factors in Chronic Kidney Disease Stage 3
Natasha J. McIntyre et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
RAGE biology, atherosclerosis and diabetes
Drazenka Pongrac Barlovic et al.
CLINICAL SCIENCE (2011)
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
Melinda T. Coughlan et al.
DIABETES (2011)
Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-year follow-up study
Johanna W. Nin et al.
DIABETES CARE (2011)
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes Potential role of AGER1 and SIRT1
Jaime Uribarri et al.
DIABETES CARE (2011)
Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes
F. Shimizu et al.
DIABETOLOGIA (2011)
Targeted reduction of advanced glycation improves renal function in obesity
Brooke E. Harcourt et al.
KIDNEY INTERNATIONAL (2011)
Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients
Kenichi Tanaka et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Alex Odermatt
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases
Ines Birlouez-Aragon et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)
Elizabeth F. O. Kern et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease
Andries J. Smit et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
Nina Reiniger et al.
DIABETES (2010)
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
K. C. Sourris et al.
DIABETOLOGIA (2010)
Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients
Pei-chun Chao et al.
EUROPEAN JOURNAL OF NUTRITION (2010)
The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding
HaJeung Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Serum Carboxymethyl-Lysine, a Dominant Advanced Glycation End Product, Is Associated With Chronic Kidney Disease: The Baltimore Longitudinal Study of Aging
Richard D. Semba et al.
JOURNAL OF RENAL NUTRITION (2010)
Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
Jaime Uribarri et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2010)
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
Giuseppina Basta et al.
KIDNEY INTERNATIONAL (2010)
Dietary Advanced Glycation End Products and Aging
Claudia Luevano-Contreras et al.
NUTRIENTS (2010)
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
Adeline L. Y. Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
Karly C. Sourris et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
RAGE: a novel biological and genetic marker for vascular disease
Anastasia Z. Kalea et al.
CLINICAL SCIENCE (2009)
Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate Synthesis
Zhengshan Zhao et al.
ENDOCRINOLOGY (2009)
Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults
Richard D. Semba et al.
EUROPEAN JOURNAL OF NUTRITION (2009)
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
Anastasia Z. Kalea et al.
FASEB JOURNAL (2009)
Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
Helen Vlassara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury
Shan Zeng et al.
JOURNAL OF HEPATOLOGY (2009)
Plasma Carboxymethyl-Lysine, an Advanced Glycation End Product, and All-Cause and Cardiovascular Disease Mortality in Older Community-Dwelling Adults
Richard D. Semba et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
RAGE-induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Melinda T. Coughlan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice
Shinji Hagiwara et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan
Weijing Cai et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Plasma concentration and urinary excretion of N-epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants
Katarina Sebekova et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis
Kikuo Isoda et al.
ATHEROSCLEROSIS (2008)
Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines
Brian P. Shapiro et al.
CIRCULATION (2008)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin
Aylin M. Ozdemir et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs
Ryoji Nagai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects
Jaime Uribarri et al.
DIABETES CARE (2007)
Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients
Sascha Gross et al.
TRANSPLANTATION (2007)
Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet - Association with increased AGER1 expression
Weijing Cai et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model
J. X. Feng et al.
KIDNEY INTERNATIONAL (2007)
Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging
Jaime Uribarri et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Effect of baking process on postprandial metabolic consequences: randomized trials in normal and type 2 diabetic subjects
S. W. Rizkalla et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2007)
AGE, RAGE, and ROS in diabetic nephropathy
Adeline L. Y. Ton et al.
SEMINARS IN NEPHROLOGY (2007)
Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy
Mark E. Williams et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Advanced glycation end products and nephrotoxicity of high-protein diets
Jaime Uribarri et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
Giuseppina Basta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes
Y. Yu et al.
DIABETOLOGIA (2006)
Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products
Christina Hultsch et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
RAGE control of diabetic nephropathy in a mouse model -: Effects of RAGE gene disruption and administration of low-molecular weight heparin
Khin-Mar Myint et al.
DIABETES (2006)
Connective tissue growth factor plays an important role in advance glycation end product-induced tubular epithelial-to-mesenchymal transition: Implications for diabetic renal disease
Wendy C. Burns et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats
Veronika Somoza et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice
F. Zheng et al.
KIDNEY INTERNATIONAL (2006)
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans
Diego Geroldi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Methylglyoxal impairs the insulin signaling pathways independently of the. formation of intracellular reactive oxygen species
A Riboulet-Chavey et al.
DIABETES (2006)
Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice
LJN Jensen et al.
JOURNAL OF ENDOCRINOLOGY (2006)
An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients
V Schwenger et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Impact of nutrition on ageing and disease
S Bengmark
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients
R Meerwaldt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
H Koyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake
O Sandu et al.
DIABETES (2005)
Glycoxidation and inflammation in renal failure patients
M Peppa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway
JH Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications
AE Buchs et al.
EXPERIMENTAL DIABESITY RESEARCH (2004)
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes
MC Thomas et al.
KIDNEY INTERNATIONAL (2004)
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
CY Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Advanced glycoxidation end products in commonly consumed foods
T Goldberg et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2004)
Enhanced expression of receptor for advanced glycation end products in chronic kidney disease
FF Hou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α -: Dependent pathway
V Thallas-Bonke et al.
DIABETES (2004)
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding
G Sorci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
A Flyvbjerg et al.
DIABETES (2004)
Advanced glycation end products activate Smad signaling via TGF-beta-dependent and -independent mechanisms: implications for diabetic renal and vascular disease
JH Li et al.
FASEB JOURNAL (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients
J Uribarri et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
The breakdown of pre-existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes
JM Forbes et al.
FASEB JOURNAL (2003)
Fetal or neonatal low glycotoxin environment prevents autoimmune diabetes in NOD mice
M Peppa et al.
DIABETES (2003)
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats
NL Alderson et al.
KIDNEY INTERNATIONAL (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
K Sebeková et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
PJ Thornalley
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice
M Peppa et al.
DIABETES (2003)
Maillard reaction products in tissue proteins: New products and new perspectives
SR Thorpe et al.
AMINO ACIDS (2003)
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
H Vlassara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease
LG Bucciarelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
SM Hofmann et al.
DIABETES (2002)
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
F Zheng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
TP Degenhardt et al.
KIDNEY INTERNATIONAL (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
A Bierhaus et al.
DIABETES (2001)
The AGE-receptor in the pathogenesis of diabetic complications
H Vlassara
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Nε-(carboxymethyl)lysine levels in patients with type 2 diabetes:: Role of renal function
Z Wagner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice
SB Schwedler et al.
DIABETES OBESITY & METABOLISM (2001)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice
T Kislinger et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction
V Faist et al.
ANNALS OF NUTRITION AND METABOLISM (2001)
Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats
PS Oturai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation
MM Sousa et al.
LABORATORY INVESTIGATION (2000)
Mechanisms for the formation of glycoxidation products in end-stage renal disease
MF Weiss et al.
KIDNEY INTERNATIONAL (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation
ME Cooper et al.
DIABETOLOGIA (2000)
Share Paper
